Share This

Related Topics News -

     
 Detail   |   Print 
     
康諾亞治療鼻竇炎伴鼻息肉注射液藥品上市許可申請獲內地受理
2024-06-07T  
康諾亞司普奇拜單抗注射液III期臨床試驗安全性良好
2024-06-03T  
康諾亞報告CMG901I期臨床研究數據最新結果
2024-06-02T  
康諾亞:司普奇拜單抗注射液納入優先審評審批程序
2024-05-23T  
《大行》大摩對中國生物科技股投資評級及目標價(表)
2024-05-08T  
《大行》大摩降信達生物目標價至66.5元 康諾亞-B下調至50元
2024-05-08T  
康諾亞-B:旗下鼻炎藥品獲國家藥監局受理上市許可申請
2024-04-30T  
中信金融資產聘任副總裁
2024-04-29T  
康諾亞司普奇拜單抗III期臨床試驗達III期
2024-04-29T  
樂普生物治療晚期實體瘤藥物臨床試驗完成首例受試者首次給藥
2024-04-15T  

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.